Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$616M |
| 2 |
Netflix
NFLX
|
+$481M |
| 3 |
Micron Technology
MU
|
+$416M |
| 4 |
Tesla
TSLA
|
+$416M |
| 5 |
Procter & Gamble
PG
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$885M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$660M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$463M |
| 4 |
Applovin
APP
|
+$430M |
| 5 |
Meta Platforms (Facebook)
META
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.84% |
| 2 | Healthcare | 15.76% |
| 3 | Consumer Discretionary | 13.86% |
| 4 | Industrials | 9.95% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1701
Caribou Biosciences
CRBU
$50.4M
| $2.61M | ﹤0.01% |
1,639,857
+859,436
| +110% | +$1.8M |
2025 Q2
2 quarters
|
|
1702
FB Bancorp
FBLA
$248M
| $2.61M | ﹤0.01% |
202,900
+159,700
| +370% | +$1.98M |
2025 Q3
1 quarter
|
|
1703
Entrada Therapeutics
TRDA
$189M
| $2.6M | ﹤0.01% |
252,635
-341,665
| -57% | -$2.88M |
2024 Q2
6 quarters
|
|
1704
Neumora Therapeutics
NMRA
$69.6M
| $2.59M | ﹤0.01% |
1,445,902
+281,926
| +24% | +$617K |
2025 Q1
3 quarters
|
|
1705
ZTO Express
ZTO
$15.5B
| $2.58M | ﹤0.01% |
123,700
-196,300
| -61% | -$3.89M |
2022 Q1
15 quarters
|
|
1706
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.56B
| $2.58M | ﹤0.01% |
40,319
+28,319
| +236% | +$1.83M |
2025 Q2
2 quarters
|
|
1707
Taylor Devices
TAYD
$182M
| $2.58M | ﹤0.01% |
44,162
+700
| +2% | +$33.9K |
2015 Q3
41 quarters
|
|
1708
Envela
ELA
$307M
| $2.57M | ﹤0.01% |
192,104
-6,600
| -3% | -$68.9K |
2019 Q4
24 quarters
|
|
1709
Starling Oncology
STLN
$683M
| $2.57M | ﹤0.01% |
721,900
-28,600
| -4% | -$106K |
2023 Q1
11 quarters
|
|
1710
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$8.02B
| $2.57M | ﹤0.01% |
+193,858
| New | +$2.62M |
2025 Q4
0 quarters
|
|
1711
OceanFirst Financial
OCFC
$1.55B
| $2.57M | ﹤0.01% |
143,043
-21,300
| -13% | -$398K |
2013 Q2
50 quarters
|
|
1712
Virtus Investment Partners
VRTS
$848M
| $2.57M | ﹤0.01% |
15,729
+13,200
| +522% | +$2.23M |
2024 Q1
7 quarters
|
|
1713
NBT Bancorp
NBTB
$2.61B
| $2.56M | ﹤0.01% |
61,773
-7,600
| -11% | -$316K |
2024 Q1
7 quarters
|
|
1714
West Fraser Timber
WFG
$5.02B
| $2.56M | ﹤0.01% |
41,900
+14,000
| +50% | +$876K |
2021 Q4
16 quarters
|
|
1715
Docebo
DCBO
$683M
| $2.55M | ﹤0.01% |
115,031
-14,102
| -11% | -$337K |
2020 Q4
20 quarters
|
|
1716
DELISTED
Repare Therapeutics
RPTX
| $2.55M | ﹤0.01% |
981,360
+257,200
| +36% | +$518K |
2021 Q2
18 quarters
|
|
1717
Mistras Group
MG
$664M
| $2.55M | ﹤0.01% |
201,600
+20,800
| +12% | +$235K |
2015 Q4
40 quarters
|
|
1718
Humana
HUM
$50.5B
| $2.55M | ﹤0.01% |
9,953
-426,847
| -98% | -$112M |
2025 Q1
3 quarters
|
|
1719
Invivyd
IVVD
$190M
| $2.54M | ﹤0.01% |
+1,026,620
| New | +$2.14M |
2025 Q4
0 quarters
|
|
1720
Vertical Aerospace
EVTL
$69.8M
| $2.53M | ﹤0.01% |
474,400
+27,200
| +6% | +$138K |
2024 Q4
4 quarters
|
|
1721
Curbline Properties
CURB
$3.11B
| $2.53M | ﹤0.01% |
+108,817
| New | +$2.54M |
2025 Q4
0 quarters
|
|
1722
Abacus Global Management
ABX
$794M
| $2.52M | ﹤0.01% |
295,000
-166,900
| -36% | -$1.1M |
2024 Q2
6 quarters
|
|
1723
CION Investment
CION
$335M
| $2.52M | ﹤0.01% |
260,800
-46,700
| -15% | -$450K |
2022 Q1
15 quarters
|
|
1724
TPG Mortgage Investment Trust
MITT
$174M
| $2.52M | ﹤0.01% |
295,741
-50,600
| -15% | -$397K |
2020 Q4
20 quarters
|
|
1725
Teradata
TDC
$2.83B
| $2.52M | ﹤0.01% |
82,632
-705,963
| -90% | -$18.5M |
2014 Q4
44 quarters
|
|
Similar funds
Renaissance Technologies's Q4 2025 Portfolio in Review
As of Q4 2025, Renaissance Technologies held 3,923 positions worth $64.5B, down 15% from $75.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $10.1B in Q4 2025, closing 736 positions and reducing 1,682 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $354M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in ServiceNow worth $204M.
- Renaissance Technologies's largest Q4 2025 buy was ServiceNow: 1,331,977 shares worth $204M.
- Renaissance Technologies added most to Costco in Q4 2025, an estimated $616M increase.
- Renaissance Technologies's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $885M.
- Renaissance Technologies fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $354M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.5B portfolio in Q4 2025.
- Renaissance Technologies opened 466 new positions and closed 736 in Q4 2025.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $64.5B.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.